Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Optimal Long Term Treatment Strategy of Anti-resorptive Medications

NCT05091086 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT05091086
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05091086 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Optimal Long Term Treatment Strategy of Anti-resorptive Medications
Lead sponsor
National Taiwan University Hospital
Phase
Phase 4
Overall status
Active, not recruiting
Start date
November 20, 2021
Completion date
December 31, 2030
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bone mineral density, osteoporosis